Ethereum

Wednesday

DeFi

Atlas

Hyperliquid

<h2 id="s-1-filing-and-share-resale-registration">S-1 Filing and Share Resale Registration</h2>
Hyperliquid Strategies (<a href="https://x.com/search?q=%24PURR&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$PURR</a>), the Nasdaq-listed treasury company built around Hyperliquid's native token <a href="https://x.com/search?q=%24HYPE&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$HYPE</a>, filed an S-1 on Wednesday to register up to 35.16 million shares for resale by Rorschach Advisors. The shares represent roughly 20.5% of outstanding stock and remain locked up until December.
The filing confirms the company holds approximately $580 million in <a href="https://x.com/search?q=%24HYPE&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$HYPE</a>, acquired at an average cost of $46.372 per token during its December 2025 reverse merger with Sonnet BioTherapeutics, alongside $310 million in cash. <cite>Hyperliquid Strategies was formed through a merger of the publicly traded healthtech firm Sonnet BioTherapeutics and Rorschach, a special purpose acquisition company with a connection to prominent crypto venture firm Paradigm.</cite><cite>The company's common stock began trading on the Nasdaq Capital Market under the ticker symbol "PURR" on December 3.</cite>
A separate $1 billion equity facility with Chardan is earmarked to fund future <a href="https://x.com/search?q=%24HYPE&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$HYPE</a> purchases, giving the company a significant ongoing acquisition runway.
<h2 id="institutional-backing-and-treasury-growth">Institutional Backing and Treasury Growth</h2>
The board is chaired by <a href="https://x.com/rediamondjr" rel="noopener noreferrer nofollow">@rediamondjr</a> (Bob Diamond) of Atlas Merchant Capital, with digital asset custody handled by Anchorage Digital. Goldman Sachs disclosed a position in <a href="https://x.com/search?q=%24PURR&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$PURR</a> through a 13F filing last quarter, adding a notable institutional endorsement to the company's growing profile.
<cite>Hyperliquid Strategies now holds about 20 million <a href="https://x.com/search?q=%24HYPE&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$HYPE</a> tokens, having deployed $216 million to acquire approximately 7.3 million tokens since its inception in December 2025.</cite><cite>Staking revenue reached $2.6 million for the three-month period ended March 31, while interest income added another $1 million.</cite>
<cite>The firm posted a $165.4 million net loss for the nine months ended March 31, primarily attributable to $64 million in net unrealized losses on its <a href="https://x.com/search?q=%24HYPE&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$HYPE</a> tokens, a one-time $35.6 million write-off related to the Sonnet acquisition, and a $60.5 million increase in deferred tax expense.</cite>
The structure draws clear comparisons to MicroStrategy's <a href="https://x.com/search?q=%24BTC&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$BTC</a> treasury playbook, adapted here for a native DeFi ecosystem. <cite>Hyperliquid is a layer one blockchain best known for perpetual futures and spot trading, with an ecosystem that also supports borrowing, lending, real world assets, and a full Ethereum Virtual Machine.</cite><cite><a href="https://x.com/search?q=%24HYPE&amp;src=cashtag_click" rel="noopener noreferrer nofollow">$HYPE</a> hit an all-time high of $61.86 on May 21, 2026.</cite>
Sources: <a href="https://www.sec.gov/Archives/edgar/data/0002078856/000119312526234992/d50758ds1.htm" rel="noopener noreferrer nofollow">Hyperliquid Strategies S-1 Filing (SEC EDGAR)</a> <a href="https://www.theblock.co/post/400512/hyperliquid-strategies-net-loss" rel="noopener noreferrer nofollow">Hyperliquid Strategies posts $165 million net loss as HYPE treasury grows (The Block)</a> <a href="https://www.sec.gov/Archives/edgar/data/0002078856/000149315225025886/ex99-1.htm" rel="noopener noreferrer nofollow">Hyperliquid Strategies and Sonnet BioTherapeutics Announce Business Combination Closing (SEC EDGAR)</a>

Hyperliquid Strategies files S-1 as the public HYPE play scales up

Table of Contents

BSCN

Other articles published on May 23, 2026

Join our free newsletter for daily crypto updates!